BackZhengye Biotechnology Holding Limited Overview

Zhengye Biotechnology Holding Limited Other Current Liabilities

Track Zhengye Biotechnology Holding Limited's other current liabilities ($3.4M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Liabilities
$3.39M
39.10% YoYΔ $-2.17M vs prior year quarter

Peer trimmed avg / median

Loading

Zhengye Biotechnology Holding Limited Other Current Liabilities History

Loading

Zhengye Biotechnology Holding Limited vs. peers: Other Current Liabilities Comparison

Loading

Zhengye Biotechnology Holding Limited Other Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Zhengye Biotechnology Holding Limited (ZYBT) FAQ

As of the most recent data (December 2025), ZYBT shows a other current liabilities of $3.4M. That compares with $5.6M in the prior-year period — down 39.1% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ZYBT's other current liabilities is now $3.4M (was $5.6M) — a 39.1% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Zhengye Biotechnology Holding Limited is outperforming or lagging.

Tracking ZYBT's other current liabilities over time shows whether Zhengye Biotechnology Holding Limited is scaling, shrinking, or reshaping that part of the business. The current reading is $3.4M That compares with $5.6M in the prior-year period — down 39.1% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current liabilities page, Stockcircle has Zhengye Biotechnology Holding Limited's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current liabilities (currently $3.4M) with ownership activity and broader fundamentals.